Atopic dermatitis increases the risk of infective endocarditis in prosthetic heart valve patients – A retrospective study

Atopic dermatitis increases the risk of infective endocarditis in prosthetic heart valve patients – A retrospective study

Saved in:

Bibliographic Details
Main Authors:	Chapman Wei, MD, Ahmad Mustafa, MD, Radu Grovu, MD, Angela Rosenberg, DO, Alaukika Agarwal, MD, Alanna Davis, MD, Nawal Mustafa, MD, Stefan Bradu, MD, Suzanne El-Sayegh, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	JAAD International
Subjects:	asthma atopic dermatitis bacteremia cannabinoid use eczema infective endocarditis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328724001743
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis
by: Makiko Kido-Nakahara, MD, et al.
Published: (2024-11-01)

Racial and ethnic disparities in dupilumab for pediatric atopic dermatitis in Florida
by: Urdur Jonsdottir, MD, et al.
Published: (2024-11-01)

Atopic dermatitis in childhood and pubertal development: A nationwide cohort studyCapsule Summary
by: Camilla Lomholt Kjersgaard, MD, et al.
Published: (2025-04-01)

A systematic review of guidelines for the management of atopic dermatitis in children
by: Maya Deva, MBBS, et al.
Published: (2024-12-01)

Correlation of serum Vitamin D levels and disease severity in patients with atopic dermatitis: A hospital-based, cross-sectional study from North India
by: Shreya Malhan, et al.
Published: (2024-12-01)

Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life
by: Andrew Blauvelt, et al.
Published: (2022-07-01)

The wide variety of methotrexate dosing regimens for the treatment of atopic dermatitis: a systematic review
by: Anouk G. M. Caron, et al.
Published: (2024-12-01)

Dupilumab‐related ocular surface disorders in a paediatric cohort with atopic dermatitis, treated in a tertiary paediatric hospital in London
by: Anjali Rampersad, et al.
Published: (2024-12-01)

The Association between Atopic Dermatitis Severity and Mood Disturbance among Adults: A Cross-sectional Study
by: Farah F. Albakr, et al.
Published: (2024-12-01)

Prevalence of food allergy and its association with atopic dermatitis in Iran: Results from the PERSIAN birth cohort
by: Kylie Jungles, MD, et al.
Published: (2025-02-01)

Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History
by: Andrew Blauvelt, et al.
Published: (2024-10-01)

Effect of Therapeutic Patient Education in Adults with Atopic Dermatitis: Analysis of Efficacy and Treatment Needs
by: Marine Fargeas, et al.
Published: (2024-12-01)

Prevalence, severity, and risk factors of eczema among young children and adolescents in Saudi Arabia: A national cross-sectional study, 2019
by: Sawsan Al Nahas, MBBS, DFE, ABHS, et al.
Published: (2024-11-01)

Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
by: Stamatios Gregoriou, et al.
Published: (2025-01-01)

COVID-19 related epigenetic changes and atopic dermatitis: An exploratory analysis
by: Zhenwei Tang, MD, et al.
Published: (2025-01-01)

Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry
by: Jonathan I. Silverberg, et al.
Published: (2024-12-01)

Subcutaneous immunoglobulin-induced eczematous dermatitis
by: Rachel Breidbart, BS, et al.
Published: (2025-02-01)

Serum Th1, Th2, Th17, and innate immune system biomarkers are elevated in pediatric alopecia areata with and without concurrent atopic dermatitis: A cross-sectional study
by: Ryan S.Q. Geng, MSc, et al.
Published: (2025-02-01)

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01)

Update Management of Atopic Dermatitis
by: Indri Widya Sari, et al.
Published: (2024-11-01)

Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis
by: Andrew Blauvelt, et al.
Published: (2025-12-01)

Incidence of cardiovascular events in a population-based Danish cohort with atopic dermatitis
by: Alexander Egeberg, MD, PhD, et al.
Published: (2024-11-01)

Baricitinib as monotherapy and with topical corticosteroids in moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of dose-response
by: Ibrahim H. I. Almoghayer, et al.
Published: (2024-11-01)

Modern treatment methods in atopic dermatitis - literature overview
by: Martyna Borowska-Łygan, et al.
Published: (2025-01-01)

Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals
by: Giovanni Paolino, et al.
Published: (2024-12-01)

Charactirestics of vitamin D level in patients with atopic dermatitis
by: E. Garibeh, et al.
Published: (2022-09-01)

Probiotics in atopic dermatitis: Where do we stand?
by: Rashmi Agarwal, et al.
Published: (2023-01-01)

Global trends in immune mediated inflammatory diseases: Psoriasis, atopic dermatitis, multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis
by: Andrea Gelabert-Mora, MD, et al.
Published: (2025-02-01)

Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus
by: Mark Boguniewicz, MD, et al.
Published: (2024-12-01)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01)

Patients’ and caregivers’ perspectives of the atopic dermatitis journey
by: Steven R. Feldman, et al.
Published: (2024-12-01)

The role of microRNAs in atopic dermatitis
by: Mahsa Khosrojerdi, et al.
Published: (2024-12-01)

Mistakes in the diagnosis and treatment of atopic dermatitis
by: Monika Marko, et al.
Published: (2024-02-01)

The Significance of Blood Eosinophilia in Atopic Dermatitis
by: Naeem N. Alhayan ., et al.
Published: (2021-06-01)

Risk Factors Associated with Weight Gain during Treatment with Dupilumab among Patients with Moderate to Severe Atopic Dermatitis
by: Mahsa Tayefi, et al.
Published: (2024-11-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

Effect of benralizumab on inflammation in skin after intradermal allergen challenge in patients with moderate-to-severe atopic dermatitis
by: Christiane E. Whetstone, BSc, et al.
Published: (2024-11-01)

Recent updates on systemic treatment of atopic dermatitis
by: Jiyoung Ahn
Published: (2024-11-01)

Current and Future Concepts in Treatment of Childhood Atopic Dermatitis Review
by: Elif Karakoç Aydıner, et al.
Published: (2011-04-01)

Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review
by: Misuzu Tsunoda, MD, et al.
Published: (2024-11-01)